Compare AMAR REMEDIES with BATA INDIA - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

AMAR REMEDIES vs BATA INDIA - Comparison Results

BATA INDIA 
   Change

Bata is India's largest footwear retailer of India. It is a part of the Bata Shoe Organisation and was incorporated in the year 1931. The company also manufactures footwear and has a wide retail network of over 1200 stores across India. It sells over... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    AMAR REMEDIES BATA INDIA AMAR REMEDIES/
BATA INDIA
 
P/E (TTM) x -0.5 2,154.3 - View Chart
P/BV x 0.1 10.6 0.6% View Chart
Dividend Yield % 0.0 0.3 -  

Financials

 AMAR REMEDIES   BATA INDIA
EQUITY SHARE DATA
    AMAR REMEDIES
Jun-12
BATA INDIA
Mar-20
AMAR REMEDIES/
BATA INDIA
5-Yr Chart
Click to enlarge
High Rs1641,897 8.6%   
Low Rs861,017 8.5%   
Sales per share (Unadj.) Rs261.6237.8 110.0%  
Earnings per share (Unadj.) Rs17.425.6 68.0%  
Cash flow per share (Unadj.) Rs22.348.6 45.8%  
Dividends per share (Unadj.) Rs04.00 0.0%  
Dividend yield (eoy) %00.3 0.0%  
Book value per share (Unadj.) Rs100.7147.4 68.4%  
Shares outstanding (eoy) m26.16128.53 20.4%   
Bonus/Rights/Conversions ---  
Price / Sales ratio x0.56.1 7.8%   
Avg P/E ratio x7.256.9 12.6%  
P/CF ratio (eoy) x5.630.0 18.7%  
Price / Book Value ratio x1.29.9 12.5%  
Dividend payout %015.6 0.0%   
Avg Mkt Cap Rs m3,270187,281 1.7%   
No. of employees `000NA4.9 0.0%   
Total wages/salary Rs m1633,764 4.3%   
Avg. sales/employee Rs ThNM6,220.5-  
Avg. wages/employee Rs ThNM766.2-  
Avg. net profit/employee Rs ThNM669.6-  
INCOME DATA
Net Sales Rs m6,84430,561 22.4%  
Other income Rs m21687 3.1%   
Total revenues Rs m6,86531,248 22.0%   
Gross profit Rs m1,1318,321 13.6%  
Depreciation Rs m1282,958 4.3%   
Interest Rs m3981,177 33.8%   
Profit before tax Rs m6264,872 12.8%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m-500-   
Tax Rs m1211,583 7.6%   
Profit after tax Rs m4553,290 13.8%  
Gross profit margin %16.527.2 60.7%  
Effective tax rate %19.332.5 59.5%   
Net profit margin %6.610.8 61.8%  
BALANCE SHEET DATA
Current assets Rs m4,90420,033 24.5%   
Current liabilities Rs m3,5818,007 44.7%   
Net working cap to sales %19.339.3 49.1%  
Current ratio x1.42.5 54.7%  
Inventory Days Days124104 119.1%  
Debtors Days Days1008 1,325.4%  
Net fixed assets Rs m1,68913,893 12.2%   
Share capital Rs m262643 40.8%   
"Free" reserves Rs m2,35818,297 12.9%   
Net worth Rs m2,63518,939 13.9%   
Long term debt Rs m50710,354 4.9%   
Total assets Rs m6,86237,325 18.4%  
Interest coverage x2.65.1 50.1%   
Debt to equity ratio x0.20.5 35.2%  
Sales to assets ratio x1.00.8 121.8%   
Return on assets %12.412.0 103.9%  
Return on equity %17.317.4 99.4%  
Return on capital %31.020.7 150.1%  
Exports to sales %4.00-   
Imports to sales %00-   
Exports (fob) Rs m273NA-   
Imports (cif) Rs mNANA-   
Fx inflow Rs m273202 135.3%   
Fx outflow Rs m23,047 0.1%   
Net fx Rs m271-2,845 -9.5%   
CASH FLOW
From Operations Rs m-3135,817 -5.4%  
From Investments Rs m-489-1,890 25.8%  
From Financial Activity Rs m769-4,361 -17.6%  
Net Cashflow Rs m-33-434 7.5%  

Share Holding

Indian Promoters % 25.5 0.0 -  
Foreign collaborators % 0.0 53.0 -  
Indian inst/Mut Fund % 9.2 9.8 93.9%  
FIIs % 0.0 20.1 -  
ADR/GDR % 0.0 0.0 -  
Free float % 65.3 17.1 381.9%  
Shareholders   13,061 83,621 15.6%  
Pledged promoter(s) holding % 99.7 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare AMAR REMEDIES With:   GODREJ CONSUMER  KARUTURI GLOBAL  K.S.OILS  BAJAJ CONSUMER CARE  MARICO  

Compare AMAR REMEDIES With:   UNILEVER PLC. (UK)  P&G (US)  HYPERMARCAS (Brazil)  



Today's Market

Sensex Tanks 531 Points; Reliance Industries & IndusInd Bank Fall 5%(Closing)

Indian share markets witnessed huge selling pressure today and failed to hold on to their opening gains as profit booking and weakness across all sectors erased gains.

Related Views on News

BATA INDIA 2019-20 Annual Report Analysis (Annual Result Update)

Aug 20, 2020 | Updated on Aug 20, 2020

Here's an analysis of the annual report of BATA INDIA for 2019-20. It includes a full income statement, balance sheet and cash flow analysis of BATA INDIA. Also includes updates on the valuation of BATA INDIA.

BATA INDIA Announces Quarterly Results (4QFY20); Net Profit Down 57.4% (Quarterly Result Update)

May 26, 2020 | Updated on May 26, 2020

For the quarter ended March 2020, BATA INDIA has posted a net profit of Rs 376 m (down 57.4% YoY). Sales on the other hand came in at Rs 6 bn (down 8.8% YoY). Read on for a complete analysis of BATA INDIA's quarterly results.

BATA INDIA Announces Quarterly Results (3QFY20); Net Profit Up 13.6% (Quarterly Result Update)

Feb 7, 2020 | Updated on Feb 7, 2020

For the quarter ended December 2019, BATA INDIA has posted a net profit of Rs 1 bn (up 13.6% YoY). Sales on the other hand came in at Rs 8 bn (up 6.5% YoY). Read on for a complete analysis of BATA INDIA's quarterly results.

BATA INDIA Announces Quarterly Results (2QFY20); Net Profit Up 28.2% (Quarterly Result Update)

Nov 15, 2019 | Updated on Nov 15, 2019

For the quarter ended September 2019, BATA INDIA has posted a net profit of Rs 714 m (up 28.2% YoY). Sales on the other hand came in at Rs 7 bn (up 7.3% YoY). Read on for a complete analysis of BATA INDIA's quarterly results.

BATA INDIA Announces Quarterly Results (1QFY20); Net Profit Up 22.0% (Quarterly Result Update)

Aug 5, 2019 | Updated on Aug 5, 2019

For the quarter ended June 2019, BATA INDIA has posted a net profit of Rs 1 bn (up 22.0% YoY). Sales on the other hand came in at Rs 9 bn (up 10.6% YoY). Read on for a complete analysis of BATA INDIA's quarterly results.

More Views on News

Most Popular

Time to Book Profits in Pharma Stocks(Fast Profits Daily)

Jan 15, 2021

In this video, I'll show you why it might be the right time to take money of the table in pharma stocks.

Smallcap Stocks: Your Best Bet for 2021 and Beyond(Profit Hunter)

Jan 15, 2021

The pandemic failed to thwart Richa's investing success formula for 2020.

One Chart to See Before You Sell(Fast Profits Daily)

Jan 22, 2021

In this video, I'll show you a crucial chart that you need to check before you decide to sell any stock or index.

Invest in the Multibaggers of 2021 and Beyond(Profit Hunter)

Jan 21, 2021

Our ace stock picker is ready to capitalise on a big growth opportunity.

More

India's #1 Trader
Reveals His Secrets

Secret To Increasing Your Trading Profits Today
Get this Special Report,
The Secret to Increasing Your Trading Profits Today, Now!
We will never sell or rent your email id.
Please read our Terms

AMAR REMEDIES SHARE PRICE


Dec 11, 2013 (Close)

TRACK AMAR REMEDIES

  • Track your investment in AMAR REMEDIES with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

AMAR REMEDIES 8-QTR ANALYSIS

COMPARE AMAR REMEDIES WITH

MARKET STATS